Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 10 studies | 31% ± 11% | |
glutamatergic neuron | 10 studies | 48% ± 24% | |
GABAergic neuron | 9 studies | 47% ± 22% | |
endothelial cell | 9 studies | 28% ± 12% | |
astrocyte | 8 studies | 31% ± 13% | |
retinal cone cell | 7 studies | 42% ± 19% | |
interneuron | 6 studies | 47% ± 23% | |
retina horizontal cell | 6 studies | 24% ± 7% | |
microglial cell | 5 studies | 22% ± 4% | |
oligodendrocyte | 5 studies | 30% ± 11% | |
neuron | 4 studies | 24% ± 8% | |
club cell | 4 studies | 22% ± 7% | |
type I pneumocyte | 4 studies | 26% ± 6% | |
GABAergic interneuron | 3 studies | 39% ± 7% | |
Mueller cell | 3 studies | 21% ± 4% | |
hepatocyte | 3 studies | 64% ± 17% | |
ependymal cell | 3 studies | 36% ± 17% | |
granule cell | 3 studies | 27% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 1972.61 | 2583 / 2642 | 94% | 4.94 | 661 / 705 |
stomach | 95% | 244.44 | 340 / 359 | 77% | 2.02 | 219 / 286 |
intestine | 91% | 245.70 | 877 / 966 | 62% | 1.28 | 325 / 527 |
esophagus | 62% | 129.16 | 901 / 1445 | 88% | 3.33 | 161 / 183 |
breast | 75% | 288.31 | 346 / 459 | 70% | 3.15 | 788 / 1118 |
prostate | 84% | 165.42 | 207 / 245 | 36% | 0.62 | 182 / 502 |
liver | 90% | 369.93 | 203 / 226 | 27% | 0.54 | 110 / 406 |
adrenal gland | 56% | 147.05 | 144 / 258 | 57% | 2.77 | 132 / 230 |
lung | 50% | 72.02 | 287 / 578 | 51% | 1.23 | 592 / 1155 |
kidney | 91% | 183.44 | 81 / 89 | 8% | 0.16 | 73 / 901 |
bladder | 67% | 105.29 | 14 / 21 | 31% | 0.61 | 157 / 504 |
ovary | 21% | 24.85 | 37 / 180 | 76% | 2.00 | 325 / 430 |
uterus | 56% | 87.29 | 96 / 170 | 31% | 0.58 | 141 / 459 |
skin | 67% | 157.33 | 1209 / 1809 | 13% | 0.25 | 62 / 472 |
blood vessel | 69% | 142.85 | 918 / 1335 | 0% | 0 | 0 / 0 |
heart | 57% | 95.94 | 491 / 861 | 0% | 0 | 0 / 0 |
pancreas | 22% | 27.32 | 71 / 328 | 21% | 0.37 | 37 / 178 |
adipose | 39% | 54.79 | 471 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 29% | 0.47 | 13 / 45 |
thymus | 3% | 3.25 | 19 / 653 | 14% | 0.21 | 83 / 605 |
peripheral blood | 7% | 11.72 | 67 / 929 | 0% | 0 | 0 / 0 |
muscle | 1% | 1.62 | 11 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
spleen | 1% | 1.17 | 2 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1901381 | Biological process | positive regulation of potassium ion transmembrane transport |
GO_0060307 | Biological process | regulation of ventricular cardiac muscle cell membrane repolarization |
GO_1902514 | Biological process | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
GO_0003062 | Biological process | regulation of heart rate by chemical signal |
GO_2000170 | Biological process | positive regulation of peptidyl-cysteine S-nitrosylation |
GO_0045428 | Biological process | regulation of nitric oxide biosynthetic process |
GO_0050999 | Biological process | regulation of nitric-oxide synthase activity |
GO_0098974 | Biological process | postsynaptic actin cytoskeleton organization |
GO_0098901 | Biological process | regulation of cardiac muscle cell action potential |
GO_0006809 | Biological process | nitric oxide biosynthetic process |
GO_1901841 | Biological process | regulation of high voltage-gated calcium channel activity |
GO_1905026 | Biological process | positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0030018 | Cellular component | Z disc |
GO_0005739 | Cellular component | mitochondrion |
GO_0042383 | Cellular component | sarcolemma |
GO_0002102 | Cellular component | podosome |
GO_0030175 | Cellular component | filopodium |
GO_0030315 | Cellular component | T-tubule |
GO_0005829 | Cellular component | cytosol |
GO_0070161 | Cellular component | anchoring junction |
GO_0033017 | Cellular component | sarcoplasmic reticulum membrane |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005901 | Cellular component | caveola |
GO_0005634 | Cellular component | nucleus |
GO_0050998 | Molecular function | nitric-oxide synthase binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0030235 | Molecular function | nitric-oxide synthase regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NOS1AP |
Protein name | Nitric oxide synthase 1 adaptor protein Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (C-terminal PDZ ligand of neuronal nitric oxide synthase protein) (Nitric oxide synthase 1 adaptor protein) |
Synonyms | KIAA0464 CAPON |
Description | FUNCTION: Adapter protein involved in neuronal nitric-oxide (NO) synthesis regulation via its association with nNOS/NOS1. The complex formed with NOS1 and synapsins is necessary for specific NO and synapsin functions at a presynaptic level. Mediates an indirect interaction between NOS1 and RASD1 leading to enhance the ability of NOS1 to activate RASD1. Competes with DLG4 for interaction with NOS1, possibly affecting NOS1 activity by regulating the interaction between NOS1 and DLG4 (By similarity). In kidney podocytes, plays a role in podosomes and filopodia formation through CDC42 activation . . |
Accessions | E9PSG0 ENST00000464284.1 ENST00000530878.5 [O75052-3] ENST00000493151.1 [O75052-2] ENST00000361897.10 [O75052-1] E9PIP8 O75052 ENST00000430120.3 |